LTS13769 - NeoGAA long-term treatment study

• Research type

  Research Study

• Full title

  An open-label, multicenter, multinational extension study of the long-term safety and pharmacokinetics of repeated biweekly infusions of neoGAA in patients with Pompe disease.

• IRAS ID

  143060

• Contact name

  Volker Straub

• Contact email

  volker.straub@newcastle.ac.uk

• Sponsor organisation

  Genzyme Corporation

• Eudract number

  2013-003321-28

• Clinicaltrials.gov Identifier

  NCT02032524

• REC name

  North East - Newcastle & North Tyneside 1 Research Ethics Committee

• REC reference

  14/NE/0150

• Date of REC Opinion

  25 Jun 2014

• REC opinion

  Favourable Opinion